Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Reduce" by Analysts

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been assigned a consensus recommendation of "Reduce" from the ten analysts that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $5.10.

Several analysts have issued reports on DH shares. Barclays lowered their target price on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating on the stock in a research note on Monday, March 3rd. The Goldman Sachs Group boosted their price objective on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a research note on Monday, May 12th. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday. Finally, BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock opened at $3.80 on Friday. The business's fifty day simple moving average is $3.17 and its 200 day simple moving average is $3.69. The firm has a market capitalization of $564.83 million, a P/E ratio of -0.87, a price-to-earnings-growth ratio of 6.61 and a beta of 1.58. Definitive Healthcare has a 12 month low of $2.15 and a 12 month high of $6.16. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. The business had revenue of $59.19 million for the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. Definitive Healthcare's quarterly revenue was down 6.8% compared to the same quarter last year. During the same period last year, the company posted $0.08 earnings per share. As a group, analysts anticipate that Definitive Healthcare will post 0.16 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of DH. Goldman Sachs Group Inc. boosted its holdings in Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company's stock valued at $25,191,000 after acquiring an additional 7,404,363 shares during the period. Irenic Capital Management LP boosted its holdings in Definitive Healthcare by 9.2% during the 4th quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock valued at $28,783,000 after acquiring an additional 590,009 shares during the period. Palisade Capital Management LP boosted its holdings in Definitive Healthcare by 1.3% during the 1st quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company's stock valued at $6,546,000 after acquiring an additional 29,774 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Definitive Healthcare by 1.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,863,912 shares of the company's stock valued at $7,661,000 after acquiring an additional 23,410 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Definitive Healthcare by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company's stock valued at $5,231,000 after acquiring an additional 39,938 shares during the period. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.